Literature DB >> 35438784

Bilateral Giant Familial Carotid Body Tumors With Concomitant Skull-Base Paraganglioma and Facial Nerve Palsy.

Nwadinma U Emeruem1, Christopher C Muoghalu2, Ndubueze Ezemba1.   

Abstract

Carotid body tumors, rare neck paragangliomas arising from the common carotid artery bifurcation, can be classified as sporadic, hyperplastic, or familial. The familial type is often bilateral and associated with germline mutation of the mitochondrial enzyme succinate dehydrogenase. We report the rare case of a 42-year-old man who presented with bilateral giant familial carotid body tumors associated with a concomitant skull-base paraganglioma, left-sided facial nerve palsy, and an incomplete circle of Willis. We describe the excision of the tumors in 2 stages (the left mass and associated paraganglioma first and the right mass second), 6 months apart, with use of general anesthesia, and we discuss other operative considerations.
© 2022 by the Texas Heart® Institute, Houston.

Entities:  

Keywords:  Carotid body tumor/classification/diagnosis/pathology/surgery; cranial nerve diseases; facial nerve diseases; head and neck neoplasms/pathology/surgery; paraganglioma/diagnosis/therapy; treatment outcome

Mesh:

Year:  2022        PMID: 35438784      PMCID: PMC9053652          DOI: 10.14503/THIJ-20-7370

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  15 in total

1.  Paraganglioma of the carotid body: treatment strategy and SDH-gene mutations.

Authors:  J Fruhmann; J B Geigl; P Konstantiniuk; T U Cohnert
Journal:  Eur J Vasc Endovasc Surg       Date:  2013-02-19       Impact factor: 7.069

Review 2.  Treatment of cervical paragangliomas.

Authors:  M Makeieff; J Thariat; E Reyt; C-A Righini
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2012-09-27       Impact factor: 2.080

3.  Diagnosis and surgical treatment of carotid body tumor: A retrospective analysis of 58 patients.

Authors:  Qingquan Hua; Zhen Xu; Yang Jiang
Journal:  Oncol Lett       Date:  2017-07-15       Impact factor: 2.967

4.  Important observations made managing carotid body tumors during a 25-year experience.

Authors:  Allan J Kruger; Philip J Walker; Wallace J Foster; Jason S Jenkins; Nicholas S Boyne; Julie Jenkins
Journal:  J Vasc Surg       Date:  2010-12       Impact factor: 4.268

5.  Carotid Body Tumor Resection: Just as Safe without Preoperative Embolization.

Authors:  Adrienne N Cobb; Adel Barkat; Witawat Daungjaiboon; Pegge Halandras; Paul Crisostomo; Paul C Kuo; Bernadette Aulivola
Journal:  Ann Vasc Surg       Date:  2017-07-08       Impact factor: 1.466

6.  A Systematic Review and Meta-Analysis of the Presentation and Surgical Management of Patients With Carotid Body Tumours.

Authors:  Vaux Robertson; Federica Poli; Ben Hobson; Athanasios Saratzis; A Ross Naylor
Journal:  Eur J Vasc Endovasc Surg       Date:  2019-03-20       Impact factor: 7.069

Review 7.  Diagnostic and Therapeutic Difficulties in Carotid Body Paragangliomas, Based on Clinical Experience and a Review of the Literature.

Authors:  Karolina Dorobisz; Tadeusz Dorobisz; Hanna Temporale; Tomasz Zatoński; Marzena Kubacka; Mariusz Chabowski; Andrzej Dorobisz; Tomasz Kręcicki; Dariusz Janczak
Journal:  Adv Clin Exp Med       Date:  2016 Nov-Dec       Impact factor: 1.727

8.  Multi-institutional survey of carotid body tumors in Japan.

Authors:  Aya Ikeda; Kiyoto Shiga; Katsunori Katagiri; Daisuke Saito; Jun Miyaguchi; Shin-Ichi Oikawa; Kodai Tsuchida; Takahiro Asakage; Hiroyuki Ozawa; Ken-Ichi Nibu; Naoki Ohtsuki; Yasushi Fujimoto; Ken-Ichi Kaneko
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

Review 9.  Paraganglioma: carotid body tumor.

Authors:  Jacqueline A Wieneke; Alice Smith
Journal:  Head Neck Pathol       Date:  2009-08-23

10.  Diagnosis and treatment of a carotid body tumor: A case report of a rare bilateral tumor.

Authors:  Qiang Sun; Chenlu Xie; Zhixing Niu; Lei Su; Xi Wang; Zheng Fang; Junfang Zhao; Shuai Chen; Xinming Li; Minglei Sun
Journal:  Oncol Lett       Date:  2017-09-28       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.